MedPath

The effect of incretins to serum growth hormone levels in acromegalic patients during oral and intravenous glucose administration tests.

Not Applicable
Conditions
Acromegaly
Registration Number
JPRN-UMIN000006516
Lead Sponsor
Department of Medicine II, Hokkaido University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who do not agreed with written consent form. Patients who have the diseases, which may affect the result of endocrine tests, such as infectious, hepatic, and renal disorders. Poor controlled diabetic patients, because they are not appropriate for the glucose loading test. Patients who are inappropriate for this study by research director.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of the paradoxical increase of growth hormone in oral glucose tolerance test. Changes of serum growth hormone levels during intravenous glucose loading test and sitagliptin loading test in the patients with paradoxical growth hormone increase.
Secondary Outcome Measures
NameTimeMethod
Changes of serum growth hormone levels in pharmacological loading tests in the patients with or without the paradoxical increase.
© Copyright 2025. All Rights Reserved by MedPath